Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
Yi Duan, Cristina Llorente, Sonja Lang, Katharina Brandl, Huikuan Chu, Lu Jiang, Richard C White, Thomas H Clarke, Kevin Nguyen, Manolito Torralba, Yan Shao, Jinyuan Liu, Adriana Hernandez-Morales, Lauren Lessor, Imran R Rahman, Yukiko Miyamoto, Melissa Ly, Bei Gao, Weizhong Sun, Roman Kiesel, Felix Hutmacher, Suhan Lee, Meritxell Ventura-Cots, Francisco Bosques-Padilla, Elizabeth C Verna, Juan G Abraldes, Robert S Brown Jr, Victor Vargas, Jose Altamirano, Juan Caballería, Debbie L Shawcross, Samuel B Ho, Alexandre Louvet, Michael R Lucey, Philippe Mathurin, Guadalupe Garcia-Tsao, Ramon Bataller, Xin M Tu, Lars Eckmann, Wilfred A van der Donk, Ry Young, Trevor D Lawley, Peter Stärkel, David Pride, Derrick E Fouts, Bernd Schnabl, Yi Duan, Cristina Llorente, Sonja Lang, Katharina Brandl, Huikuan Chu, Lu Jiang, Richard C White, Thomas H Clarke, Kevin Nguyen, Manolito Torralba, Yan Shao, Jinyuan Liu, Adriana Hernandez-Morales, Lauren Lessor, Imran R Rahman, Yukiko Miyamoto, Melissa Ly, Bei Gao, Weizhong Sun, Roman Kiesel, Felix Hutmacher, Suhan Lee, Meritxell Ventura-Cots, Francisco Bosques-Padilla, Elizabeth C Verna, Juan G Abraldes, Robert S Brown Jr, Victor Vargas, Jose Altamirano, Juan Caballería, Debbie L Shawcross, Samuel B Ho, Alexandre Louvet, Michael R Lucey, Philippe Mathurin, Guadalupe Garcia-Tsao, Ramon Bataller, Xin M Tu, Lars Eckmann, Wilfred A van der Donk, Ry Young, Trevor D Lawley, Peter Stärkel, David Pride, Derrick E Fouts, Bernd Schnabl
Abstract
Chronic liver disease due to alcohol-use disorder contributes markedly to the global burden of disease and mortality1-3. Alcoholic hepatitis is a severe and life-threatening form of alcohol-associated liver disease. The gut microbiota promotes ethanol-induced liver disease in mice4, but little is known about the microbial factors that are responsible for this process. Here we identify cytolysin-a two-subunit exotoxin that is secreted by Enterococcus faecalis5,6-as a cause of hepatocyte death and liver injury. Compared with non-alcoholic individuals or patients with alcohol-use disorder, patients with alcoholic hepatitis have increased faecal numbers of E. faecalis. The presence of cytolysin-positive (cytolytic) E. faecalis correlated with the severity of liver disease and with mortality in patients with alcoholic hepatitis. Using humanized mice that were colonized with bacteria from the faeces of patients with alcoholic hepatitis, we investigated the therapeutic effects of bacteriophages that target cytolytic E. faecalis. We found that these bacteriophages decrease cytolysin in the liver and abolish ethanol-induced liver disease in humanized mice. Our findings link cytolytic E. faecalis with more severe clinical outcomes and increased mortality in patients with alcoholic hepatitis. We show that bacteriophages can specifically target cytolytic E. faecalis, which provides a method for precisely editing the intestinal microbiota. A clinical trial with a larger cohort is required to validate the relevance of our findings in humans, and to test whether this therapeutic approach is effective for patients with alcoholic hepatitis.
Conflict of interest statement
Competing interests
B.S. is consulting for Ferring Research Institute. However, there is no competing interest with regard to this study. All other authors declare no competing interests.
Figures
References
- Lozano R et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095–2128 (2012).
- Lee BP, Vittinghoff E, Dodge JL, Cullaro G & Terrault NA National trends and long-term outcomes of liver transplant for alcohol-associated liver disease in the United States. JAMA Intern Med 179, 340–348 (2019).
- Rehm J et al. Burden of disease associated with alcohol use disorders in the United States. Alcohol Clin Exp Res 38, 1068–1077 (2014).
- Llopis M et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut 65, 830–839 (2016).
- Ike Y, Clewell DB, Segarra RA & Gilmore MS Genetic analysis of the pAD1 hemolysin/bacteriocin determinant in Enterococcus faecalis: Tn917 insertional mutagenesis and cloning. J Bacteriol 172, 155–163 (1990).
- Tang W & van der Donk WA The sequence of the enterococcal cytolysin imparts unusual lanthionine stereochemistry. Nat Chem Biol 9, 157–159 (2013).
- Maddrey WC et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75, 193–199 (1978).
- Dominguez M et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol 103, 2747–2756 (2008).
- Thursz MR et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med 372, 1619–1628 (2015).
- Mathurin P & Lucey MR Management of alcoholic hepatitis. J Hepatol 56 Suppl 1, S39–S45 (2012).
- Llorente C et al. Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat Commun 8, 837 (2017).
- Gilmore MS et al. Genetic structure of the Enterococcus faecalis plasmid pAD1-encoded cytolytic toxin system and its relationship to lantibiotic determinants. J Bacteriol 176, 7335–7344 (1994).
- Cox CR, Coburn PS & Gilmore MS Enterococcal cytolysin: a novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells. Curr Protein Pept Sci 6, 77–84 (2005).
- Van Tyne D, Martin MJ & Gilmore MS Structure, function, and biology of the Enterococcus faecalis cytolysin. Toxins (Basel) 5, 895–911 (2013).
- Bertola A, Mathews S, Ki SH, Wang H & Gao B Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc 8, 627–637 (2013).
- Ogilvie LA & Jones BV The human gut virome: a multifaceted majority. Front Microbiol 6, 918 (2015).
- Chatterjee A et al. Bacteriophage resistance alters antibiotic-mediated intestinal expansion of enterococci. Infect Immun 87, pii: e00085–19 (2019).
- Poindexter JS Biological properties and classification of the Caulobacter group. Bacteriol Rev 28, 231–295 (1964).
- Shin J et al. Analysis of the mouse gut microbiome using full-length 16S rRNA amplicon sequencing. Sci Rep 6, 29681 (2016).
- The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486, 207–214 (2012).
- Marcuk LM et al. Clinical studies of the use of bacteriophage in the treatment of cholera. Bull World Health Organ 45, 77–83 (1971).
- Sarker SA et al. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMedicine 4, 124–137 (2016).
- Dalmasso M, Hill C & Ross RP Exploiting gut bacteriophages for human health. Trends Microbiol 22, 399–405 (2014).
- Ujmajuridze A et al. Adapted bacteriophages for treating urinary tract infections. Front Microbiol 9, 1832 (2018).
- Khawaldeh A et al. Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection. J Med Microbiol 60, 1697–1700 (2011).
- Schooley RT et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother 61, pii: e00954–17 (2017).
- Dedrick RM et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med 25, 730–733 (2019).
- Fish R et al. Compassionate use of bacteriophage therapy for foot ulcer treatment as an effective step for moving toward clinical trials. Methods Mol Biol 1693, 159–170 (2018).
- Gorski A et al. Phages and immunomodulation. Future Microbiol 12, 905–914 (2017).
- Brandl K et al. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis. J Hepatol 69, 396–405 (2018).
- Gao B et al. Serum and fecal oxylipins in patients with alcohol-related liver disease. Dig Dis Sci 64, 1878–1892 (2019).
- Lang S et al. Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis. Hepatology, doi: 10.1002/hep.30832 (2019).
- Ball SA, Tennen H, Poling JC, Kranzler HR & Rounsaville BJ Personality, temperament, and character dimensions and the DSM-IV personality disorders in substance abusers. J Abnorm Psychol 106, 545–553 (1997).
- Krieg L et al. Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice. Blood 118, 6418–6425 (2011).
- Gill JJ et al. The Caulobacter crescentus phage phiCbK: genomics of a canonical phage. BMC Genomics 13, 542 (2012).
- Wick RR, Judd LM, Gorrie CL & Holt KE Completing bacterial genome assemblies with multiplex MinION sequencing. Microb Genom 3, e000132 (2017).
- Wick RR, Judd LM, Gorrie CL & Holt KE Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13, e1005595 (2017).
- Walker BJ et al. Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS One 9, e112963 (2014).
- Santiago-Rodriguez TM et al. Transcriptome analysis of bacteriophage communities in periodontal health and disease. BMC Genomics 16, 549 (2015).
- Haft DH et al. RefSeq: an update on prokaryotic genome annotation and curation. Nucleic Acids Res 46, D851–D860 (2018).
- Tatusova T et al. NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res 44, 6614–6624 (2016).
- Fouts DE Phage_Finder: automated identification and classification of prophage regions in complete bacterial genome sequences. Nucleic Acids Res 34, 5839–5851 (2006).
- Ondov BD et al. Mash: fast genome and metagenome distance estimation using MinHash. Genome Biol 17, 132 (2016).
- Paradis E & Schliep K Ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R. Bioinformatics 35, 526–528 (2019).
- Letunic I & Bork P Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees. Nucleic Acids Res 44, W242–W245 (2016).
- Valentine RC, Shapiro BM & Stadtman ER Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia coli. Biochemistry 7, 2143–2152 (1968).
- Haas BJ et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res 21, 494–504 (2011).
- Caporaso JG et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A 108 Suppl 1, 4516–4522 (2011).
- Chen P et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology 148, 203–214 (2015).
- Ryu H et al. Development of quantitative PCR assays targeting the 16S rRNA genes of Enterococcus spp. and their application to the identification of Enterococcus species in environmental samples. Appl Environ Microbiol 79, 196–204 (2013).
- Haas W, Shepard BD & Gilmore MS Two-component regulator of Enterococcus faecalis cytolysin responds to quorum-sensing autoinduction. Nature 415, 84–87 (2002).
- Page AJ et al. Robust high-throughput prokaryote de novo assembly and improvement pipeline for Illumina data. Microb Genom 2, e000083 (2016).
- Chen L et al. VFDB: a reference database for bacterial virulence factors. Nucleic Acids Res 33, D325–D328 (2005).
- Jia B et al. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res 45, D566–D573 (2017).
- Seemann T Prokka: rapid prokaryotic genome annotation. Bioinformatics 30, 2068–2069 (2014).
- Stamatakis A RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30, 1312–1313 (2014).
- Tang W, Bobeica SC, Wang L & van der Donk WA CylA is a sequence-specific protease involved in toxin biosynthesis. J Ind Microbiol Biotechnol 46, 537–549 (2019).
- Iwaisako K et al. Protection from liver fibrosis by a peroxisome proliferator-activated receptor delta agonist. Proc Natl Acad Sci U S A 109, E1369–E1376 (2012).
- Clarke TH, Brinkac LM, Sutton G & Fouts DE GGRaSP: a R-package for selecting representative genomes using Gaussian mixture models. Bioinformatics 34, 3032–3034 (2018).
Source: PubMed